HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Linda E Wellik Selected Research

Ligands

1/2017Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Linda E Wellik Research Topics

Disease

6Neoplasms (Cancer)
10/2023 - 01/2012
3Lymphoma (Lymphomas)
01/2021 - 01/2012
3Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2018 - 03/2012
3Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2017 - 11/2012
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2017 - 05/2009
1Urinary Calculi (Urinary Calculus)
01/2022
1Carcinogenesis
12/2021
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
12/2021
1Waldenstrom Macroglobulinemia (Macroglobulinemia)
01/2020
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
11/2018
1Burkitt Lymphoma (Burkitt's Lymphoma)
03/2012
1Disease Progression
03/2012
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2012
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2012
1Sezary Syndrome (Sezary Erythroderma)
01/2012
1Primary Myelofibrosis (Myelosclerosis)
01/2005
1Hematologic Neoplasms (Hematological Malignancy)
01/2005

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
01/2021 - 11/2018
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2012 - 01/2005
2Sirolimus (Rapamycin)FDA Link
03/2012 - 01/2012
1Protein Isoforms (Isoforms)IBA
10/2023
1Long Noncoding RNAIBA
12/2021
1Glutathione (Reduced Glutathione)IBA
01/2020
1Immunoglobulin M (IgM)IBA
01/2020
1Tyrosine (L-Tyrosine)FDA Link
11/2018
1ibrutinibIBA
01/2017
1LigandsIBA
01/2017
16- (4- (1H- 1,2,4- triazol- 3- yl)phenyl)- 1- (2- (tetrahydro- 2H- pyran- 4- yl)ethyl)- 1H- imidazo(4,5- b)pyrazin- 2(3H)- oneIBA
04/2015
1Phosphotransferases (Kinase)IBA
04/2015
1Eukaryotic Initiation Factor-4EIBA
04/2015
1Eukaryotic Initiation Factor-4F (EIF4F)IBA
04/2015
1Eukaryotic Initiation Factor-4G (Eukaryotic Initiation Factor 4G)IBA
04/2015
1Cyclin D3IBA
04/2015
1epratuzumabIBA
11/2012
1Rituximab (Mabthera)FDA Link
11/2012
1Sorafenib (BAY 43-9006)FDA Link
03/2012
1OSI 027IBA
01/2012
1TOR Serine-Threonine KinasesIBA
01/2012
1Mechanistic Target of Rapamycin Complex 1IBA
01/2012
1Mechanistic Target of Rapamycin Complex 2IBA
01/2012

Therapy/Procedure

3Therapeutics
11/2018 - 11/2012
1Nephrectomy
01/2022